Literature DB >> 15577802

Habitual risk factors for head and neck cancer.

David Goldenberg1, Juna Lee, Wayne M Koch, Michael M Kim, Barry Trink, David Sidransky, Chul-So Moon.   

Abstract

UNLABELLED: Chronic tobacco smoking and alcohol consumption are well-established risk factors for the development of squamous cell carcinoma (SCC) of the head and neck. There are, however, a variety of other habitual and culturally based activities that are less commonly seen in the Western world and that are also risks factors for the development of this type of cancer. In this era of globalization, many of these habits have now crossed borders and appear in various areas throughout the world. This article reviews habitual and social risk factors for cancer of the head and neck, excluding smoking and alcohol consumption. These factors include chewing tobacco and snuff, areca nut in its various forms, Khat leaves, and the drinking of Mate. EBM RATING: D.

Entities:  

Mesh:

Year:  2004        PMID: 15577802     DOI: 10.1016/j.otohns.2004.02.035

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  29 in total

1.  Pan masala habits and risk of oral precancer: A cross-sectional survey in 0.45 million people of North India.

Authors:  Divya Mehrotra; Sumit Kumar; Shambhavi Mishra; Sandeep Kumar; Prashant Mathur; C M Pandey; Arvind Pandey; Kishore Chaudhry
Journal:  J Oral Biol Craniofac Res       Date:  2016-12-29

Review 2.  Emerging biomarkers in head and neck cancer in the era of genomics.

Authors:  Hyunseok Kang; Ana Kiess; Christine H Chung
Journal:  Nat Rev Clin Oncol       Date:  2014-11-18       Impact factor: 66.675

Review 3.  Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions.

Authors:  Ala-Eddin Al Moustafa; Rana Al-Awadhi; Nabiha Missaoui; Ishag Adam; Raika Durusoy; Lina Ghabreau; Nizar Akil; Hussain Gadelkarim Ahmed; Amber Yasmeen; Ghazi Alsbeih
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.

Authors:  Marilia F Calmon; Rodrigo V Rodrigues; Carla M Kaneto; Ricardo P Moura; Sabrina D Silva; Louise Danielle C Mota; Daniel G Pinheiro; Cesar Torres; Alex F de Carvalho; Patrícia M Cury; Fabio D Nunes; Ines Nobuko Nishimoto; Fernando A Soares; Adriana M A da Silva; Luis P Kowalski; Helena Brentani; Cleslei F Zanelli; Wilson A Silva; Paula Rahal; Eloiza H Tajara; Dirce M Carraro; Anamaria A Camargo; Sandro R Valentini
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

5.  Health-related quality of life differences between African Americans and non-Hispanic whites with head and neck cancer.

Authors:  Bryce B Reeve; Jianwen Cai; Hongtao Zhang; Jaeun Choi; Mark C Weissler; David Cella; Andrew F Olshan
Journal:  Head Neck       Date:  2012-08-21       Impact factor: 3.147

6.  Altered expression of SIRT gene family in head and neck squamous cell carcinoma.

Authors:  Chi-Chih Lai; Pai-Mei Lin; Sheng-Fung Lin; Cheng-Hsien Hsu; Hsin-Ching Lin; Ming-Luen Hu; Cheng-Ming Hsu; Ming-Yu Yang
Journal:  Tumour Biol       Date:  2013-03-12

Review 7.  Khat - a controversial plant.

Authors:  Erica E Balint; George Falkay; Gabor A Balint
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 8.  Oral premalignancy: the roles of early detection and chemoprevention.

Authors:  Jean-Philippe Foy; Chloé Bertolus; William N William; Pierre Saintigny
Journal:  Otolaryngol Clin North Am       Date:  2013-05-25       Impact factor: 3.346

9.  Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers.

Authors:  Ranee Mehra; Fang Zhu; Dong-Hua Yang; Kathy Q Cai; Joellen Weaver; Mahendra K Singh; Anna S Nikonova; Erica A Golemis; Douglas B Flieder; Harry S Cooper; Miriam Lango; John A Ridge; Barbara Burtness
Journal:  Clin Cancer Res       Date:  2013-10-02       Impact factor: 12.531

10.  The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer.

Authors:  Mohamedtaki A Tejani; Roger B Cohen; Ranee Mehra
Journal:  Biologics       Date:  2010-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.